| Project/Area Number |
22791505
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Urology
|
|---|
| Research Institution | Kinki University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2011: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2010: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | 前立腺癌 / 癌ワクチン / HLA-A3 supertype alleles / ペプチドワクチン / テーラーメイド |
|---|
| Research Abstract |
Peripheral blood mononuclear cells(PBMCs) were obtained from prostate cancer patients. The PBMCs were prepared by Ficoll-Conray density gradient centrifugation. The expression of HLA-A11,-A31, and-A33 molecules on the PBMCs was determined by flow cytometry using these antibodies-anti-HLA-A11,-A31,-A33-and FITC-conjugated anti-mouse IgG monoclonal antibodies. 3 prostate cancer-related antigens prepared based on the binding motifs to the MHC-class I alleles. It is predicted as a peptide candidate that be identified induction of specific CTL with EZHp_<733-741> peptide in CTL assay, and can apply to a cancer vaccine treatment.
|
